ViiV initiates phase II study of GSK-3810109A in antiretroviral-naive HIV-1-infected adults July 12, 2021
Study to assess analytical treatment interruption in participants who contracted HIV in VRC-01 trial April 6, 2021
HTI vaccines show promise for virus control without ART in patients with early HIV infection March 17, 2021
RSS